Physician Assistant · Rochester, NY
NPI
1306871652
Since 2006
Specialty
Physician Assistant
Code 363A00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2101 Lac de Ville Blvd Ste 1
Rochester, NY, 14618
Phone (585) 546-3265
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$601K
1,343 prescriptions
Company payments, 2025
$8,983
From 36 companies
Medicare prescription drug claims, 2024
In 2024, the drug Christina T Hatfield prescribed most often to Medicare patients was Nurtec Odt (Rimegepant Sulfate), with 125 prescriptions and refills. In total Christina T Hatfield wrote 1,343 Medicare prescriptions that cost $601K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Nurtec Odt Rimegepant Sulfate | 125 | 127 | 19 | $162K |
| Ajovy Autoinjector Fremanezumab-Vfrm | 109 | 149 | 19 | $102K |
| Gabapentin Generic | 76 | 151 | 20 | $1,097 |
| Emgality Pen Galcanezumab-Gnlm | 75 | 89 | 12 | $59K |
| Sumatriptan Succinate Generic | 69 | 80 | 18 | $7,298 |
| Ubrelvy Ubrogepant | 67 | 82 | 14 | $93K |
| Topiramate Generic | 64 | 152 | 21 | $709 |
| Aimovig Autoinjector Erenumab-Aooe | 57 | 61 | Under 11 | $43K |
| Rizatriptan Rizatriptan Benzoate | 44 | 46 | 12 | $465 |
| Qulipta Atogepant | 42 | 46 | Under 11 | $48K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 38 | 70 | 15 | $1,446 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 36 | 37 | Under 11 | $608 |
| Pregabalin Generic | 34 | 48 | Under 11 | $572 |
| Cyclobenzaprine Hcl Generic | 33 | 49 | Under 11 | $408 |
| Ajovy Syringe Fremanezumab-Vfrm | 33 | 41 | Under 11 | $30K |
Brand drugs: 548 claims; generic drugs: 795 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christina T Hatfield $8,983 ($8,983 in general payments such as food, travel and fees) from 36 companies. The largest payer was Genzyme Corporation with $5,741.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 19 | $5,741 |
| Abbvie Inc. ABBV | 55 | $774 |
| Genentech USA, Inc. ROG.SW | 5 | $232 |
| TG Therapeutics, Inc. TGTX | 4 | $213 |
| Pfizer Inc. PFE | 14 | $190 |
| UCB, Inc. UCB.BR | 5 | $143 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $127 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $117 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $116 |
| Lundbeck LLC | 5 | $112 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.